Tag: Bispecifics
T-Therapeutics reloads with $133M to push TCR bispecifics to patients
A Cambridge spinout betting on fully human T cell receptors has raised an oversubscribed Series B to move two programs…
A Cambridge spinout betting on fully human T cell receptors has raised an oversubscribed Series B to move two programs…